olivLaw · US equity research
Aduro Clean Technologies Inc. ADUR
Chemicals & Allied Products · SIC 2800 · Vertical: Chemicals & Allied Products (SIC 2800)
At the close of 04 Nov 2026, Aduro Clean Technologies Inc. (ADUR) stock was 9.87 USD (+5.67% on the day), with beta 1.58, 52-week range 9.19–17.16 USD.
Data as of · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 39.0
- weak (30–45)
- Bollinger (20, 2)
- 9.17 – 11.07
- in the lower half of the band · %B 0.37 · band width 18.7%
- SMA 50 / 200
- 11.81 / 12.90
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.62 / -0.69
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −18.6% | −1.1% | −17.5 pp | — |
| 3 months | −36.2% | −0.5% | −35.8 pp | — |
| 6 months | −29.5% | +4.4% | −33.9 pp | — |
| Year to date | −4.7% | +12.3% | −17.0 pp | — |
| 1 year | −29.1% | +13.5% | −42.7 pp | +3.3% |
| 3 years | unavailable | +76.4% | unavailable | −36.5% |
| 5 years | unavailable | +63.7% | unavailable | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
the price (USD) and the reports are in different currencies
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 337.5 k | 231.2 k |
| Revenue YoY | unavailable | −31.5% |
| Net income | -7.4 m | -12.1 m |
| Net income YoY | unavailable | unavailable |
| Diluted EPS | -0.36 | -0.45 |
| Diluted EPS YoY | unavailable | unavailable |
| net % | -2,203.4% | -5,253.1% |
| Free cash flow | -6.4 m | -10.4 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 May 2025
- Cash
- 7.0 m CAD
- Financial debt
- unavailable CAD
- Net debt
- unavailable CAD
- Equity
- 11.8 m CAD
- Total assets
- 12.8 m CAD
- Debt / equity
- unavailable
- Current ratio
- 16.19x
- ROE
- -133.8%
- ROA
- -122.7%
- FCF margin
- -4,508.6%
Financial statements (source on every figure)
Revenue and net income (CAD)
Margins
Income statement · CAD
| Line | 2024 | 2025 | Source (latest year) |
|---|---|---|---|
| Revenue | 337.5 k | 231.2 k | SEC (XBRL)· 27 Aug 2025verified |
| Research & development | 3.3 m | 5.5 m | SEC (XBRL)· 27 Aug 2025verified |
| Operating income | -7.4 m | -11.9 m | SEC (XBRL)· 27 Aug 2025verified |
| Depreciation & amortisation | 431.2 k | 536.3 k | SEC (XBRL)· 27 Aug 2025verified |
| EBITDA | -7.0 m ≈ | -11.4 m ≈ | SEC (XBRL)· 27 Aug 2025derived |
| Interest expense | 13.3 k | 12.3 k | SEC (XBRL)· 27 Aug 2025verified |
| Income tax | 0 | 0 | SEC (XBRL)· 27 Aug 2025verified |
| Net income | -7.4 m | -12.1 m | SEC (XBRL)· 27 Aug 2025verified |
| Diluted EPS | -0.36 | -0.45 | SEC (XBRL)· 27 Aug 2025verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · CAD
| Line | 2024 | 2025 | Source (latest year) |
|---|---|---|---|
| Cash | 2.8 m | 7.0 m | SEC (XBRL)· 27 Aug 2025verified |
| Current assets | 3.7 m | 8.6 m | SEC (XBRL)· 27 Aug 2025verified |
| Property, plant & equipment, net | 3.1 m | 4.1 m | SEC (XBRL)· 27 Aug 2025verified |
| Total assets | 7.0 m | 12.8 m | SEC (XBRL)· 27 Aug 2025verified |
| Accounts payable | 461.9 k | 468.0 k | SEC (XBRL)· 27 Aug 2025verified |
| Current liabilities | 502.3 k | 528.7 k | SEC (XBRL)· 27 Aug 2025verified |
| Equity | 6.4 m | 11.8 m | SEC (XBRL)· 27 Aug 2025verified |
| Shares outstanding at year end | — | 29.6 m | SEC (XBRL)· 27 Aug 2025verified |
Cash flow · CAD
| Line | 2024 | 2025 | Source (latest year) |
|---|---|---|---|
| Operating cash flow | -5.2 m | -9.0 m | SEC (XBRL)· 27 Aug 2025verified |
| Capex | 1.1 m | 1.4 m | SEC (XBRL)· 27 Aug 2025verified |
| Free cash flow | -6.4 m ≈ | -10.4 m ≈ | SEC (XBRL)· 27 Aug 2025derived |
| Investing cash flow | -1.1 m | -1.4 m | SEC (XBRL)· 27 Aug 2025verified |
| Financing cash flow | 5.1 m | 14.6 m | SEC (XBRL)· 27 Aug 2025verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
Risk
Valuation
olivLaw classification
- indicators available: 3 of at least 6
- score weight coverage: 16.7% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: unavailable
Price and reporting are in different currencies; market indicators are unavailable.
Key indicators
Coverage and freshness
The data is older than the freshness threshold.
Score by group
17% · Insufficient data
Estimated value range
unavailable — no valuation assumptions for the reporting currency
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 6.5%
- Equity risk premium
- 6.0%
- Beta (default)
- 1.00
- Cost of equity
- 12.5%
- Terminal growth
- 3.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 3 of at least 6; score weight coverage: 16.7% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | -5,253.1% | 0 (vs peers) | 38% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -968.9x | 0 (on a fixed band) | 38% |
| Current ratio · Balance sheet | 16.2x | 100 (on a fixed band) | 25% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet40/100 · 2/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality· partial0/100 · 1/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partialunavailable · 0/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
ADURO CLEAN TECHNOLOGIES INC. (ADUR). Latest full fiscal year: 2025; data up to 2025-05-31.
Figures computed from the financial statements: revenue 231.2 k CAD in 2025; YoY growth -31.5%; net margin -5,253.1%; ROE -133.8%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (indicators available: 3 of at least 6; score weight coverage: 16.7% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Current ratio: 16.2x
What contradicts it
- Net margin: -5,253.1%
- Interest coverage: -968.9x
Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Chemicals & Allied Products (SIC 2800) · same industry (4-digit SIC) · compared with 14 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| SOLSSolstice Advanced Materials Inc. | 9.1 bn | 28.3 | 13.6% | 7.8% | +3.1% | +21% / unavailable |
| BCPCBalchem Corporation | 5.8 bn | 34.4 | 13.0% | 15.4% | +8.8% | +17% / +46% |
| PRMPerimeter Solutions, Inc. | 4.6 bn | — | -30.9% | -44.9% | +16.4% | +1% / +575% |
| NGVTIngevity Corporation | 2.5 bn | 50.1 | 64.4% | 4.7% | −2.7% | +41% / +90% |
| CCThe Chemours Company | 2.1 bn | — | -339.7% | -5.2% | +0.4% | +8% / −50% |
| OLNOlin Corporation | 2.1 bn | — | -12.2% | -3.3% | +3.7% | −14% / −62% |
| IOSPInnospec Inc. | 2.0 bn | 14.2 | 10.5% | 7.5% | −3.7% | +8% / −23% |
| HUNHuntsman Corporation | 1.7 bn | — | -11.8% | -5.8% | −5.8% | −5% / −60% |
| ECVTEcovyst Inc. | 1.1 bn | — | -9.6% | -7.1% | +20.9% | +8% / +5% |
| FMCFmc Corporation | 998.7 m | — | -226.7% | -151.2% | −18.3% | −55% / −88% |
| ACNTAscent Industries Co. | 124.0 m | — | -1.1% | -1.0% | −7.2% | −3% / +68% |
| CITRCitroTech Inc. | 54.8 m | — | -431.0% | -1,788.4% | +194.6% | unavailable / unavailable |
| LOOPLoop Industries, Inc. | 13.0 m | — | — | -2,154.3% | −95.3% | −77% / −92% |
| GUREGulf Resources, Inc. | 5.6 m | — | -32.4% | -134.4% | +231.8% | +3% / −80% |
| ADURAduro Clean Technologies Inc. | — | — | -133.8% | -5,253.1% | −31.5% | −29% / unavailable |
1- and 3-year price returns: for ADUR from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Scenarios are not available. input data missing
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report (foreign issuer)19 Oct 2026
- Current report (foreign issuer)16 Oct 2026
- Current report (foreign issuer)25 Jun 2026
- Current report (foreign issuer)12 Jun 2026
- Current report (foreign issuer)11 Jun 2026
- Current report (foreign issuer)10 Jun 2026
- Current report (foreign issuer)15 Apr 2026
- Current report (foreign issuer)02 Feb 2026
- Current report (foreign issuer)15 Jan 2026
- Current report (foreign issuer)23 Dec 2025
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.